Displaying items 25-36 of 62
» View wsbtradio.com items only
< Previous
1
2
3
4
5
6
Next >
-
Big pharma: Few new antibiotics in the works
Thirty years ago, when the world faced the terrifying prospect of an untreatable disease known as AIDS, big drugmakers saw an opportunity and raced to develop new medicines. Today, as the world confronts the crisis of antibiotic resistance, the industry...Tags: Tuberculosis, Food and Drug Administration, Lilly Eli & Co, Economy, Business and Finance, AstraZeneca Plc
-
Too many drug types are compromising heart health: doctors
Reuters(Reuters) - About 80 million Americans suffer from heart disease, the nation's No. 1 killer, and most are on multiple drugs. Some cardiologists think prescribing has gotten out of hand. The criticism was voiced by a number of leading heart doctors who...Tags: Medical Research, Diabetes, Hospitals and Clinics, American Heart Association, Cardiologists
-
Diabetes drugs tied to pancreatitis: study
ReutersNEW YORK (Reuters Health) - People who take a certain type of diabetes drug to lower blood sugar levels may be at an increased risk of developing an inflamed pancreas, according to a new study. Glucagonlike peptide 1(GLP-1) therapies that include...Tags: American Diabetes Association, Johns Hopkins University, Medical Research, U.S. Centers for Disease Control and Prevention, Internists
-
Lazarus: Patients' choices narrower, yet cost of insurance rises
It's hard enough having a serious condition like cancer or kidney failure. It's even worse, some might think, when your health insurer says you have to buy your medicine from the pharmacy of its choice — or pay the full amount for expensive life-...Tags: Satellite and Cable Service, Drugs and Medicines, Healthcare Provider, Business, Employment Opportunities
-
GlaxoSmithKline to acquire Human Genome Sciences
After spurning a hostile takeover bid from GlaxoSmithKline PLC in April, Human Genome Sciences Inc. said Monday it agreed to be bought by the biopharmaceutical giant for a more lucrative offer valued at $3.6 billion.
GlaxoSmithKline boosted its offer for...Tags: Rockville (Bethlehem, Pennsylvania), Medical Research, Human Genome Sciences Inc., Drugs and Medicines, Benlysta (drug)
-
Developer unveils $50 million office complex
A developer on Wednesday unveiled detailed plans for a $50 million office complex that would include a 570-space underground parking garage and could attract more than 700 mostly white-collar office workers to downtown Allentown.
One City Center, to be...Tags: Finance, Services and Shopping, Property, Real Estate, Rental Service
-
Assemblyman Hall attended Kentucky Derby as fact-finder, fundraiser
PolitiCalAssemblyman Isadore Hall III (D-Compton) takes fact-finding trip to Kentucky Derby. He said taxpayers did not pay for his trip and he did not bet on a horse.... -
Romney's jobs record a little shaky
Mitt Romney stood before a shuttered steel factory in Pennsylvania the other day, using the iconic backdrop to underscore what has become the most forceful theme of his presidential campaign: the need for more jobs.
"He has done everything wrong," Romney...Tags: Finance, Allentown, Human Interest, Business, Employers
-
Hovering Parents Impede Kids' Activity?
FOX 17 NewsBack Off, Mom. Parents Who Hover Impede Kids' Activity (Source: Time.com) Parents, if you want your kids to get more exercise, you'd be wise to get out of their way. In a new study, published in the American Journal of Preventive Medicine, researchers...Tags: Entertainment, Air and Space Accidents, Medical Research, International Travel, Benito Mussolini
-
Cancer Drugs Making Splash In Scientific World
ReutersAdvanced melanoma patients treated with an experimental pill developed by Roche and Daiichi Sankyo were 63 percent less likely to die than patients given chemotherapy, according to a new trial. The drug, vemurafenib, is designed for use in patients...Tags: University of California, Skin Cancer, Medical Specialization, Squamous Cell Cancer, Health
-
Two new drugs extend survival for Melanoma patients
For the first time, patients with the deadliest form of skin cancer have two new treatment options that prolong survival, according to new research presented at a cancer conference in Chicago on Sunday. One drug specifically targets a mutated gene that...Tags: Medical Research, Drugs and Medicines, University of Pennsylvania, Health, Human Interest
-
Do you have skin? Read this story
marieg@herald-mail.comYou don't die from skin cancer. That's what Robert Harsh thought when he was diagnosed with the disease about four years ago. You go to a doctor, have the lesion removed and life goes on. But there was more to the small spot on Harsh's cheek than...Tags: Surgery, Trips and Vacations, Skin, Medical Research, Internists
Mar 19, 2013
|Story| Reuters
Mar 14, 2013
|Story| Reuters
Feb 28, 2013
|Story| Reuters
Nov 30, 2012
|Column| Los Angeles Times
Jul 16, 2012
|Story| Baltimore Sun
Dec 14, 2011
|Story| Allentown Morning Call
May 11, 2012
| Los Angeles Times
Jul 10, 2011
|Story| Los Angeles Times
Sep 20, 2011
|Story| WXMI
Jun 5, 2011
|Story| Reuters
Jun 5, 2011
|Story| KCPQ-LTV
May 29, 2011
|Story| Herald Mail
Original site for Bristol Myers Squibb Company topic gallery.